Next |
home / stock / revb / revb message board
Subject | By | Source | When |
---|---|---|---|
Ready for another move $1.08 entry consideration. $2.05 to | tw0122 | investorshub | 04/18/2023 11:07:48 AM |
Patience gonna pay - this is and still | Klinsmann | investorshub | 04/17/2023 4:04:08 PM |
DOESN'T LOOK IT !! | power11 | investorshub | 04/17/2023 4:02:27 PM |
Agree. Ripe for a VICIOUS reversal. | Lonewolf1 | investorshub | 04/17/2023 3:02:32 PM |
Any update and its going to explode... | Klinsmann | investorshub | 04/17/2023 3:00:40 PM |
MAYBE ?? | power11 | investorshub | 04/17/2023 2:31:07 PM |
Something is definitely up here. The volume says it | Lonewolf1 | investorshub | 04/17/2023 2:03:27 PM |
My first call on it was too early... | Klinsmann | investorshub | 04/17/2023 1:36:32 PM |
NICE POP TO 2.45 NOW 1.30 | TheFinalCD | investorshub | 04/17/2023 11:13:11 AM |
znewcar1: $REVB Hod 1.2100 RL.95=LL Last Post: 10/25/2022 5:19:48 PM Board Marks: 0 Posts Today: 0 B | znewcar1 | investorshangout | 04/14/2023 5:27:29 PM |
Hope so | Arnold25764 | investorshub | 03/20/2023 5:13:34 PM |
Markets need to turn in general. I still | Klinsmann | investorshub | 03/20/2023 12:06:58 PM |
Hoping for it. So far Deep Red days. | Arnold25764 | investorshub | 03/18/2023 1:06:11 AM |
A summary: | Klinsmann | investorshub | 02/28/2023 7:57:39 PM |
What about some deep green days making you | Klinsmann | investorshub | 02/28/2023 7:48:21 PM |
We ever going to see a string of | Arnold25764 | investorshub | 02/28/2023 7:32:41 PM |
Nobody here?!? Its a pity - this gonna | Klinsmann | investorshub | 02/28/2023 4:41:14 PM |
Added even more. This stock gonna generate very | Klinsmann | investorshub | 02/27/2023 5:35:00 PM |
In! Offering closes today... | Klinsmann | investorshub | 02/13/2023 3:00:46 PM |
Somebody has been loading here. | Lonewolf1 | investorshub | 01/27/2023 1:35:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Revelation Biosciences Inc. Company Name:
REVB Stock Symbol:
OTCMKTS Market:
Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three and twelve months ended...
– Prophylactic administration of Gemini (Intravenous PHAD®) reduces tissue damage and improves kidney function in a rat model of bilateral ischemic reperfusion induced acute kidney injury (AKI) - Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or ...
Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation) a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, announced today that its Chief Executive Officer James Rol...